Moxonidine Young Obese Study

An exciting new study

We are looking for overweight and obese males, aged between 18 and 30 years to participate in a new research study looking at the effect of diet and medication on organ damage. Participants may be eligible for free food supplies and will be reimbursed $300 at the completion of the study.

Study details

The Human Neurotransmitters laboratory at Baker IDI is commencing a new study looking at the effect of a drug and diet on a few health parameters, such as blood pressure and kidney function. The drug is called moxonidine and is currently used to treat hypertension.

Eligibility

To be eligible for this study, you must:

  • be a male
  • be a non-smoker
  • be overweight or obese
  • be aged between 18 and 30 years old
  • have no history of heart disease, diabetes, or mental illness
  • not be taking any medication

What happens on the study?

You will be randomised to one of four groups:

  • control
  • diet alone
  • diet + drug treatment
  • drug treatment alone

The duration of the study will be 6 months, in which you will be asked to come in for several visits to check for compliance and for a routine physical examination.

Interested?

If you would like to participate, or would like to know how you can help, please email Carolina on carolina.ikasari@bakeridi.edu.au